Securities Fraud Class Action Lawsuit Pending Against Tenax Therapeutics, Inc.: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline
BENSALEM, Pa.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired the Company's securities from November 13, 2023 through August 7, 2026, inclusive. The Law Offices of Howard G. Smith today reported the lawsuit, Katz v. Tenax Therapeutics, Inc. et al., which was filed on October 26, 2026 in the U.S. District Court North Carolina Middle Distri. ...